Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,074 public trials 1,189 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)

NCT06261125

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Mian Xi Guangzhou, Guangdong, China

View Trial Details

Recruiting

Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale

NCT06286631

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: The Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Recruiting

Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma

NCT05970666

Conditions: Adebrelimab, Adenocarcinoma, Bevacizumab, +13 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

NCT06277180

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +13 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

NCT06255197

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details

Recruiting

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

NCT05678270

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Anhui Provincial Hospital Hefei, Anhui, China

Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Peking Union Medical College Hospital Beijing, Beijing Municipality, China

Beijing Youan Hosptital,Capital Medical University Beijing, Beijing Municipality, China

View all 44 locations

View Trial Details

Recruiting

METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors

NCT05794048

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Hôpital Beaujon Clichy, France

View Trial Details

Recruiting

Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation

NCT06236568

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
Locations: AOU di Modena Modena, MO, Italy

View Trial Details

Recruiting

HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

NCT06244225

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions